By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...

Mounjaro, the weight loss injection developed by pharmaceutical firm Lilly, is set to be prescribed on the NHS for the first ...

With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...

Women on Mounjaro may miss signs of pancreatitis. Learn the symptoms, risks, and what UK health authorities are doing to ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Medication is not a quick fix for obesity, Dr. Samuel L. Wilcox said during a "Lunch & Learn" session at the Iola Public ...

There are growing concerns about the side effects caused by weight loss injections such as Ozempic, Wegovy and Mounjaro.

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...